School of Public Health, Suzhou Medical College of Soochow University, Suzhou, China.
School of Public Health, Suzhou Medical College of Soochow University, Suzhou, China; Jiangsu Key Laboratory of Preventive and Translational Medicine for Major Chronic Non-Communicable Diseases, Suzhou Medical College of Soochow University, Suzhou, China; MOE Key Laboratory of Geriatric Diseases and Immunology, Suzhou Medical College of Soochow University, Suzhou, China.
Diabetes Res Clin Pract. 2024 Nov;217:111875. doi: 10.1016/j.diabres.2024.111875. Epub 2024 Sep 29.
Lifestyle interventions are widely used among women with gestational diabetes mellitus (GDM). This study aimed to assess the ethnic disparities in the effectiveness of lifestyle interventions on reducing adverse pregnancy outcomes, particularly macrosomia and neonatal hypoglycemia among women with GDM.
We systematically searched the PubMed/MEDLINE, Web of Science, and Cochrane Library databases from January 1, 2000, up to March 31, 2024, to identify randomized controlled trials (RCTs) examining the effects of lifestyle interventions in GDM patients. Subgroup analysis was performed to investigate heterogeneity across different ethnic groups (including Asians, Whites/Caucasians, Hispanics/ Latinos, and Unknown ethnicity). The random effects model was used to calculate the relative risk (RR) and 95% confidence interval (CI).
After applying inclusion and exclusion criteria, twenty-one studies comprising 4567 participants were included. Lifestyle interventions significantly reduced the incidence of macrosomia ((RR = 0.54; 95 % CI: 0.42-0.70, P < 0.001), with consistent effects observed across racial groups. Conversely, lifestyle interventions were associated with a significant reduction in the risk of neonatal hypoglycemia only among Asians (RR = 0.56; 95 % CI: 0.38-0.84, P = 0.004), while no significant effects were observed in Whites/Caucasians or Hispanics/Latinos (all P > 0.05). Sensitivity analyses confirmed the robustness of the findings.
Regardless of ethnic background, this study emphasizes the significant benefits of lifestyle interventions in reducing the risk of macrosomia among women with GDM. However, lifestyle interventions seem to reduce the risk of neonatal hypoglycemia only among Asians, which warrants further studies.
生活方式干预在妊娠糖尿病(GDM)女性中广泛应用。本研究旨在评估生活方式干预对降低不良妊娠结局,尤其是 GDM 女性中巨大儿和新生儿低血糖风险的有效性在不同种族之间的差异。
我们系统地检索了 PubMed/MEDLINE、Web of Science 和 Cochrane Library 数据库,检索时间从 2000 年 1 月 1 日至 2024 年 3 月 31 日,以确定评估生活方式干预对 GDM 患者影响的随机对照试验(RCT)。进行了亚组分析,以调查不同种族(包括亚洲人、白种人/高加索人、西班牙裔/拉丁裔和未知种族)之间的异质性。使用随机效应模型计算相对风险(RR)和 95%置信区间(CI)。
在应用纳入和排除标准后,纳入了 21 项研究,共 4567 名参与者。生活方式干预可显著降低巨大儿的发生率(RR = 0.54;95%CI:0.42-0.70,P < 0.001),且在不同种族群体中观察到一致的效果。相反,生活方式干预仅与亚洲人群新生儿低血糖风险的显著降低相关(RR = 0.56;95%CI:0.38-0.84,P = 0.004),而在白种人/高加索人和西班牙裔/拉丁裔人群中则无显著影响(均 P > 0.05)。敏感性分析证实了研究结果的稳健性。
无论种族背景如何,本研究均强调了生活方式干预在降低 GDM 女性巨大儿风险方面的显著益处。然而,生活方式干预似乎仅能降低亚洲人群新生儿低血糖的风险,这需要进一步的研究。